ArticleJournal of pharmaceutical analysis2021

Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2.

Yury A Gubarev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.